DESIGN OF PROTEIN KINASE INHIBITORS USING STAUROSPORINE AS A LEAD
- At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
- Type: Poster
- By: SHOEMAKE, Claire (University of Malta, Pharmacy, Malta)
- Co-author(s): Elena Mallia: Pharmacy, University of Malta, Msida, Malta
Claire Shoemake: Pharmacy, University of Malta, Msida, Malta
The protein kinase C (PKc) family is a target in cancer management. PKc inhibitors have an important role in cancer chemotherapy1. Staurosporine, isolated from Streptomyces staurosporeus is an ATP-competitive kinase inhibitor capable of inducing cellular apoptosis2.
MethodsPDB crystallographic deposition 1STC describing the bound.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.